← Shanghai Children's Medical Center International Department

Li Benshang

Chief Physician; Doctoral Supervisor

Innovation Diagnosis and Treatment Center, Ward 1

Shanghai Children's Medical Center International Department

The official SCMC page presents Li Benshang as a senior specialist focused on pediatric CAR-T and related cell therapies for relapsed or refractory leukemia, lymphoma, and solid tumors.

Quick Answer

The official SCMC page presents Li Benshang as a senior specialist focused on pediatric CAR-T and related cell therapies for relapsed or refractory leukemia, lymphoma, and solid tumors.

Main conditions handled

Relapsed acute leukemia · Refractory leukemia · Lymphoma

Best for

Pediatric hematology-oncology · Cell therapy · Immunotherapy

Care approach

Pediatric CAR-T cell therapy · Cell preparation and translational cell-therapy programs

Biography

According to the official page, Li Benshang is a chief physician and doctoral supervisor in SCMC's Innovation Diagnosis and Treatment Center, Ward 1, and also directs the Cell Preparation Center. The page states that he was among the early domestic pioneers in basic and clinical cell-therapy research for relapsed or refractory pediatric acute leukemia, lymphoma, and solid tumors, and that he has participated in more than 1,000 related clinical cases. It also lists multiple academic leadership roles and overseas study or exchange at St. Jude Children's Research Hospital and the University of Hamburg.

Specialties

✓Pediatric CAR-T cell immunotherapy

✓Relapsed or refractory acute leukemia

✓Lymphoma

✓Pediatric solid tumors

✓Cell therapy exploration for autoimmune disease

Practice Areas

•Pediatric hematology-oncology
•Cell therapy
•Immunotherapy
•Translational medicine

Conditions Treated

✓Relapsed acute leukemia

✓Refractory leukemia

✓Lymphoma

✓Pediatric solid tumors

✓Selected autoimmune diseases

Clinic Schedule

•Thursday morning (specialist clinic, Zhangjiang)
•Thursday afternoon (VIP clinic, Zhangjiang)

Academic Titles

•Doctoral Supervisor
•Director of the Cell Preparation Center
•Visiting Professor at the Shanghai Institute of Hematology

Academic Roles

•Director of the Cell Preparation Center
•Visiting Professor at the Shanghai Institute of Hematology
•Vice Chair of the National Health Commission Pediatric Hematologic Diseases and Other Blood Disorders Committee
•Committee member of the National Health Commission Pediatric Leukemia Expert Committee and Deputy Head of its Clinical Translation Working Group
•Deputy Head of the New Technology Development Group of the Chinese Anti-Cancer Association Pediatric Oncology Committee
•Member of the Chinese Medical Association Pediatrics Precision Medicine Committee
•Committee member of the National Children's Medical Center Hematology/Oncology Alliance
•Principal Investigator at the National Health Commission Key Laboratory for Pediatric Hematology and Oncology
•Executive Deputy Director of the SCMC-SJCRH Joint Laboratory
•Director of the Pediatric Hematology-Oncology Translational Research Laboratory at Shanghai Jiao Tong University

Education & Overseas Experience

The reviewed official page specifically notes study or exchange at St. Jude Children's Research Hospital in the United States and the University of Hamburg in Germany. A full formal education chronology is not clearly provided in the excerpt reviewed.

Research Highlights

•Among the earlier domestic pioneers in basic and clinical cell-therapy research for relapsed or refractory pediatric leukemia, lymphoma, and solid tumors
•Completed more than 1,000 clinical cases involving relapsed or refractory pediatric hematologic and oncologic diseases
•Led or participated in studies on dual-target CD19/CD22 CAR-T therapy for pediatric acute lymphoblastic leukemia and lymphoma
•Recent projects include minimal residual disease detection using ultra-deep sequencing in pediatric leukemia and translational cell-therapy programs for refractory disease

Signature Techniques

★Pediatric CAR-T cell therapy
★Cell preparation and translational cell-therapy programs

Awards & Honors

★Official profile does not explicitly list named awards

International Patient Fit

Potentially relevant for international families seeking advanced cell therapy or CAR-T options for relapsed or refractory pediatric blood cancers or tumors. The reviewed page suggests strong translational expertise but does not explicitly outline foreign-language support or international patient workflows.

Frequently Asked Questions

Is this expert suitable for a second opinion?

Yes. Li Benshang may be a strong option for second-opinion cases involving Pediatric CAR-T cell immunotherapy, Relapsed or refractory acute leukemia, Lymphoma, especially when families want input from a leading pediatric center in Shanghai.

What kinds of cases is this expert best for?

This expert is generally best suited for cases involving Relapsed acute leukemia, Refractory leukemia, Lymphoma, based on the public SCMC profile and the doctor’s main clinical focus.

Can OriEast help arrange the appointment?

Yes. OriEast can help international families prepare records, confirm booking steps, and coordinate communication with Shanghai Children's Medical Center International Department when arranging care.

What records should patients prepare before booking?

Prepare the latest diagnosis, imaging or pathology reports, treatment summaries, medication list, and any key questions for the specialist. Clear English translations are helpful if available.